Fulcrum Therapeutics's total assets for Q2 2024 were $279.01M, a decrease of -5.18% from the previous quarter. FULC total liabilities were $21.72M for the fiscal quarter, a 6.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.